Summit Therapeutics Inc. Annual Return On Equity in % from 2019 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Summit Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2024.
  • Summit Therapeutics Inc. Return On Equity for the quarter ending June 30, 2025 was -209 %, a 34.3% decline year-over-year.
  • Summit Therapeutics Inc. annual Return On Equity for 2024 was -83.1 %, a 85.5% increase from 2023.
  • Summit Therapeutics Inc. annual Return On Equity for 2023 was -572 %, a 582% decline from 2022.
  • Summit Therapeutics Inc. annual Return On Equity for 2022 was -83.9 %, a 12.6% increase from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -83.1 +489 +85.5% Jan 1, 2024 Dec 31, 2024
2023 -572 -488 -582% Jan 1, 2023 Dec 31, 2023
2022 -83.9 +12 +12.6% Jan 1, 2022 Dec 31, 2022
2021 -95.9 -8.11 -9.23% Jan 1, 2021 Dec 31, 2021
2020 -87.8 -32.3 -58.2% Jan 1, 2020 Dec 31, 2020
2019 -55.5 Feb 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.